Stellar CrownStellar Crown🃏All Venusaur cards
Ask about Venusaur ex
Venusaur ex #1 Pokémon card from Stellar Crown

Venusaur ex 1/142

Stellar Crown

Find this card on eBay

Affiliate link · we may earn commission

Venusaur ex #1 from Stellar Crown currently trades at $1.81 raw, with PSA 10 copies reaching $64.78 — a 35.8x grade premium.
Current Prices (USD)
Ungraded
$1.81
PSA 7
$10.72
PSA 8
$12.40
PSA 9
$18.00
PSA 10
$64.78
ACE 10
BGS 10 Black
$420.00
CGC 10 Pristine
$58.84
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Venusaur ex 1/142 from Stellar Crown has a current raw market value of $1.81.

Current raw value
$1.81
PSA 9 value
$18.00
PSA 10 value
$64.78
PSA 10 premium vs raw
35.8× raw
View all cards from Stellar Crown
Collector Intel
35.8x
Raw → PSA 10
High-risk grade
9.9x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 36x the raw price. The expected value accounts for the realistic probability.
$2
Buy Raw
~$25
Grading Fee
PSA Standard
$65
PSA 10 Value
+$38
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$189.9x raw
PSA 10$6535.8x raw

Frequently asked questions

How much is Venusaur ex #1 from Stellar Crown worth?+
Venusaur ex #1 from Stellar Crown is currently worth Raw: $1.81, PSA 9: $18.00, PSA 10: $64.78 based on recent sold listings. Prices update daily from real eBay sales.
Is Venusaur ex #1 worth grading?+
The PSA 10 price of $64.78 is 35.8× the raw price of $1.81. After a ~$25 grading fee, a PSA 10 result would net approximately $62.97 — assuming the card grades a 10.
Where do PokePrices Venusaur ex #1 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.